Emerging Technologies

Molly Gibson, president of future science at Lila Sciences, discusses the company's superintelligence platform to advance scientific research, AI technology's promise in curing diseases and the risks the company is watching out for.

Anne Osdoit, CEO of Moon Surgical, discusses the company’s surgical robot, Maestro, designed for laparoscopic soft-tissue procedures, which provides surgeons with an extra set of hands so they can focus more fully on the operation itself.

Precision Neuroscience kicks off the Emerging Technologies series, with Jayme Strauss, the company’s chief clinical and commercial officer, discussing the Layer 7 cortical interface, a minimally invasive brain-computer interface.

Paul Grand, CEO of MedTech Innovator, shares how the accelerator evaluates startups for innovation and scalability and connects them with industry partners to accelerate growth and ultimately bring their offerings to market effectively.

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle machine interface that records electrical activity from one's body, decodes it and uses it to allow them to control a robotic prosthetic limb using their mind.

Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, highlights the venture capital firm's strategy for funding emerging technologies and its rigorous evaluation of a technology's potential for maturation.

Nissan Elimelech, founder of Augmedics, explains how the company’s augmented reality surgical technology allows surgeons see a virtual spine overlay directly on a patient during an operation, eliminating the need to look at a monitor.

Julien Payen, CEO and cofounder of Lattice Medical, a French American company specializing in tissue engineering, discusses Mattice—a 3D-printed scaffold, a resorbable breast implant designed for regrowing one’s own breast tissue.